scholarly journals Temporal Trends of Infective Endocarditis in North America from 2000 to 2017 – A Systematic Review

2021 ◽  
Author(s):  
Khawaja M Talha ◽  
Mark J Dayer ◽  
Martin H Thornhill ◽  
Wajeeha Tariq ◽  
Verda Arshad ◽  
...  
Keyword(s):  
Systematic Review ◽  
Staphylococcus Aureus ◽  
Infective Endocarditis ◽  
North America ◽  
Web Of Science ◽  
Temporal Trends ◽  
Population Based ◽  
Ovid Medline ◽  
Notable Increase ◽  
Future Population

Abstract Objectives To examine temporal changes of infective endocarditis (IE) incidence and epidemiology in North America. Patients and Methods A systematic review was conducted at Mayo Clinic, Rochester. Ovid EBM Reviews™, Ovid Embase™, Ovid Medline™, Scopus™, and Web of Science™ were searched for studies published between January 1, 2000 and May 31, 2020. Four referees independently reviewed all studies, and those that reported a population-based incidence of IE in patients aged 18 years and older in North America were included. Results Of 8,588 articles screened, 14 were included. Overall, IE incidence remained largely unchanged throughout the study period, except for two studies that demonstrated a rise in incidence after 2014. Five studies reported temporal trends of injection drug use (IDU) prevalence among IE patients with a notable increase in prevalence observed. Staphylococcus aureus was the most common pathogen in 7 of 9 studies that included microbiologic findings. In-patient mortality ranged from 3.7-14.4%, while the percentage of patients who underwent surgery ranged from 6.4-16.0%. Conclusion Overall incidence of IE has remained stable among the 14 population-based investigations in North America identified in our systematic review. Standardization of study design for future population-based investigations have been highlighted for use in subsequent systematic reviews of IE.

scholarly journals Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e51172 ◽  
Author(s):  
Anne Tristan ◽  
Jean-Philippe Rasigade ◽  
Esmée Ruizendaal ◽  
Frédéric Laurent ◽  
Michèle Bes ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Infective Endocarditis ◽  
Population Based

scholarly journals Household and area-level social determinants of multimorbidity: a systematic review

2020 ◽  
pp. jech-2020-214691 ◽  
Author(s):  
Elizabeth Ingram ◽  
Sarah Ledden ◽  
Sarah Beardon ◽  
Manuel Gomes ◽  
Sue Hogarth ◽  
...  
Keyword(s):  
Systematic Review ◽  
North America ◽  
General Population ◽  
Social Determinants ◽  
Household Income ◽  
Web Of Science ◽  
Household Composition ◽  
Living Alone ◽  
Study Quality ◽  
Household Level

BackgroundNo clear synthesis of evidence examining household and area-level social determinants of multimorbidity exists. This study aimed to systematically review the existing literature on associations between household and area-level social determinants of health (SDoH) and multimorbidity prevalence or incidence in the general population.MethodsSix databases (MedLine, EMBASE, PsychINFO, Web of Science, CINAHL Plus and Scopus) were searched. The search was limited to peer-reviewed studies conducted in high-income countries and published in English between 2010 and 2019. A second reviewer screened all titles with abstracts and a subset of full texts. Study quality was assessed and protocol pre-registered (CRD42019135281).Results41 studies spanning North America, Europe and Australasia were included. Household income and area-level deprivation were the most explored with fairly consistent findings. The odds of multimorbidity were up to 4.4 times higher for participants with the lowest level of income compared with the highest level. Those living in the most deprived areas had the highest prevalence or incidence of multimorbidity (pooled OR 1.42, 95% CI 1.41 to 1.42). Associations between deprivation and multimorbidity differed by age and multimorbidity type. Findings from the few studies investigating household tenure, household composition and area-level rurality were mixed and contradictory; homeownership and rurality were associated with increased and decreased multimorbidity, while living alone was found to be associated with a higher risk of multimorbidity and not associated.ConclusionImproving our understanding of broader social determinants of multimorbidity—particularly at the household level—could help inform strategies to tackle multimorbidity.

scholarly journals Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey

2012 ◽  
Vol 54 (9) ◽  
pp. 1230-1239 ◽  
Author(s):  
Christine Selton-Suty ◽  
Marie Célard ◽  
Vincent Le Moing ◽  
Thanh Doco-Lecompte ◽  
Catherine Chirouze ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Infective Endocarditis ◽  
Population Based ◽  
Population Based Survey

scholarly journals Short- and long-term outcomes of infective endocarditis admission in adults: A population-based registry study in Finland

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254553
Author(s):  
Elina Ahtela ◽  
Jarmo Oksi ◽  
Tero Vahlberg ◽  
Jussi Sipilä ◽  
Päivi Rautava ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Large Population ◽  
Temporal Trends ◽  
Population Based ◽  
Factors Affecting ◽  
Comorbidity Burden ◽  
Hospital Stays ◽  
Population Based Registry ◽  
Long Term Mortality

Infective endocarditis (IE) is associated with high mortality. However, data on factors associated with length of stay (LOS) in hospital due to IE are scarce. In addition, long-term mortality of more than 1 year is inadequately known. In this large population-based study we investigated age and sex differences, temporal trends, and factors affecting the LOS in patients with IE and in-hospital, 1-year, 5-year and 10-year mortality of IE. Data on patients (≥18 years of age) admitted to hospital due to IE in Finland during 2005–2014 were collected retrospectively from nationwide obligatory registries. We included 2166 patients in our study. Of the patients 67.8% were men. Women were older than men (mean age 63.3 vs. 59.5, p<0.001). The median LOS was 20.0 days in men and 18.0 in women, p = 0.015. In the youngest patients (18–39 years) the median LOS was significantly longer than in the oldest patients (≥80 years) (24.0 vs. 16.0 days, p = 0.014). In-hospital mortality was 10% with no difference between men and women. Mortality was 22.7% at 1 year whereas 5- and 10-year mortality was 37.5% and 48.5%, respectively. The 5-year and 10-year mortality was higher in women (HR 1.18, p = 0.034; HR 1.18, p = 0.021). Both in-hospital and long-term mortality increased significantly with aging and comorbidity burden. Both mortality and LOS remained stable over the study period. In conclusion, men had longer hospital stays due to IE compared to women. The 5- and 10-year mortality was higher in women. The mortality of IE or LOS did not change over time.

scholarly journals Sudden Onset, Acute Loss of Taste and Smell in Coronavirus Disease 2019 (COVID-19): A Systematic Review

2020 ◽  
Author(s):  
Lakshman SAMARANAYAKE ◽  
Kausar Fakhruddin ◽  
Chamila Panduwawala
Keyword(s):  
Systematic Review ◽  
Early Detection ◽  
Selection Criteria ◽  
Web Of Science ◽  
Sudden Onset ◽  
Sudden Loss ◽  
Ovid Medline ◽  
The Usa ◽  
Ebsco Host ◽  
Taste And Smell

Early detection, isolation, and management of COVID-19 patients are crucial to contain the current pandemic. The CDC in USA recently included "sudden loss of taste (dysgeusia/ageusia) and smell (anosmia/hyposmia)&rdquo; as symptoms of COVID-19. If these symptoms are reliable forerunner symptoms of COVID-19, then it may facilitate early detection and containment of the disease. Hence, we systematically evaluated the contemporary evidence on dysgeusia and anosmia as trigger symptoms in COVID-19. Ovid MEDLINE, EBSCO host, and Web of Science databases were searched between December 25, 2019-May 30, 2020.Of the 13 identified records, eight (totaling 11,054 COVID-19 patients), were included, as per the selection criteria. The studies emanated mostly from the European community, as well as China, the USA, and Iran. In total, anosmia and dysgeusia symptoms were present in 74.9 % and 81.3% ambulatory as well as hospitalized, mild-to-severe cases of COVID-19 patients, respectively. The European, US, and Iran data indicate that olfactory, and gustatory symptoms appear prior to general COVID-19 symptoms in a majority of the patients. To our knowledge, this is the first systematic review analyzing the prevalence of chemosensory dysfunction in COVID-19. Further, studies are essential to evaluate their utility as harbingers of COVID-19 onset, and to establish clinical practice guidelines.

Sign in / Sign up

Export Citation Format

Share Document